🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The defined composition and highly predictive nature of small molecule drugs - and more recently protein #biologics - have lent themselves to 'recipe' style, batch processing. However, the starting point and determination of potency for cell therapies will require additional and

Study reveals that age-related immune decline has a measurable impact on CAR-T cell therapy, one of the most advanced forms of cancer immunotherapy. bioengineer.org/study-reveals-…

Our CEO Walker Inman, PhD providing a brief overview of how the #Resipher works and how it can accelerate your research. #oxygenconsumption #cellmetabolism #cellculture #scientificresearch

In their study published in iScience, Julieta S. Del Valle et al. investigate the metabolic dysfunction and fibrosis in human ovarian tissue. Their research explores how antifibrotic and antioxidant treatments, particularly Metformin, can reverse collagen accumulation, modulate

Another one of Resipher's many applications! Continued success and big thanks to Masfique Mehedi, Ph.D. and his team for the kind words. #oxygenconsumption #metabolicresearch #resipher

In addition to #OxygenConsumption and concentration, Resipher continuously streams incubator temperature, relative humidity, atmospheric pressure, and other environmental factors. Learn more & request a free trial >>> bit.ly/44vPHJS #Mitochondrial #CellMetabolism

We're very excited to be an exhibitor and event sponsor at the 22nd SFRRI Biennial Meeting, kicking off tomorrow in Galway, Ireland. In attendance for Lucid will be VP of Sales Ryan Titmas, Sales Application Specialist Ghainaa Abousleiman, and EMEA Sales Director Mike Lu. The

We're live from day 1 of the 22nd SFRRI Biennial Meeting in Galway, Ireland! Stop by if you're in the area and learn more about our Resipher technology. #sfrri #galway #metabolism #resipher

Making great connections at #SFRRI2025! University of Galway Postdoc Dr. Rossella Parrotta pictured with Dr William Hotham and our own Ghainaa at Dr. Eva Zegezdi Laboratory, where Resipher is being utilized to help accelerate their AML (Acute Myeloid Leukemia) Research.

22nd SFRRI Biennial Meeting Galway, 3-6 June 2025…generous support Baker, BMG Labtech, Lucid Scientific, Nanion Technol., A4Cell for Physioxia Workshop (sfrrgalway2025.com) Europe-SFRR SFRBM SFRR-Australasia Elsevier Biomedchem The Baker Company BMG LABTECH Lucid Scientific, Inc. Nanion Technologies

Some significant happenings this past month, including a big step forward with #CRISPR and potential new #ALS therapy.

With the Resipher Starter Kit, you'll have everything you need to begin tracking oxygen consumption rate in just minutes, providing invaluable cellular metabolism insights: ☑️ 32-channel or 96-channel device ☑️ 8-port Hub ☑️ 5 sensing lids ☑️ All necessary cords and connectors

Researchers at the University Medical Center Göttingen have developed a new technology that can be used to alter protein production in the mitochondria of living cells. bit.ly/3ZYXa2Y

Inés Marmisolle et al. (2025) provide new insight into how mitochondrial metabolism drives the pro-inflammatory secretory phenotype (SASP) in oncogene-induced senescent (OIS) fibroblasts. The study demonstrated that OIS cells exhibit a substantial and sustained increase in

Achieving scaled delivery of cell and gene therapies requires novel, cell based instrumentation that establishes and scales quality control. Although working with living cells makes this challenging, measurable metabolic features such as oxygen consumption rate (OCR) can be

In a recent Nature paper, Caleb Cheng et al. explore how PIKfyve regulates lysosomal lipid recycling in pancreatic ductal adenocarcinoma (PDAC). Loss of PIKfyve disrupts this recycling, driving tumor cells to compensate via de novo lipogenesis. This compensatory shift opens up a